About Pharma Industry

BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.

GSK Pulls Dominican Hepatitis Risk Ads After Political Pressure

By Jim Edwards | Feb 17, 2009

GlaxoSmithKline has pulled a campaign promoting hepatitis vaccines for travelers to the Dominican Republic following political pressure from the government there, even though DR is a hotspot for hepatitis and travelers really should consider vaccinations before going.

The DR government requested the ad be pulled because it was harming tourism, according to Dominican Today. Canadians are major visitors to the island nation. GSK makes Twinrix, a hep vaccine.

The ad campaign was first noticed by the Dominican government a few days ago. It said, “You can even get it in places like the Dominican Republic; It’s almost impossible to detect where hepatitis B can be found.” GSK said that it periodically promotes the vaccination among Canadians travelers, and that this year’s campaign mentions the Dominican Republic.

Tourism minister Francisco Javier Garcia said the arrival of Canadian visitors to DR grew almost 9 percent last year, “it was key to get [sic] Dominican Republic”:

GlaxoSmithKline infers that our destination poses a risk for travelers from that country.

The damages to the image of Dominican Republic are irreparable.

DR is in fact a risky country in terms of hepatitis. This map of hep risk shows DR as an “intermediate” risk company. Most American and West European countries are low risk. Canadian travelers are still urged to get vaccines before going to certain countries, but only in the vaguest terms.

The ad ban raises the prospect that some Canadian holidaymakers may unwittingly contract hep on the island, when they could have been warned ahead of visiting.

Dominicans are divided on the issue, according to this bulletin board. Some typical posts:

Generoso: What the hell? Let’s sue the pharmaceutical bastards for slander and defamation. We have good grounds to sue them at home right where it hurts and demand $$$$ reparations.

gouletcolonial: for what telling the truth in a very nice way ….you have to be kidding

Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. Follow him on Twitter or send him an email.

BNET User Analysis

Web Buzz:
  • US FDA panel to debate Cervarix approval, Gardasil use in males

    Scrip News - 98 days 10 hours 3 minutes ago

    The US FDA's outside experts will convene on September 9th to consider the approvability of GlaxoSmithKline's cervical cancer vaccine Cervarix and a broader indication for Merck & Co's competitor Gardasil for vaccination of

  • MS patient wins French vaccine case

    Scrip News - 147 days 9 hours 32 minutes ago

    A French patient has won nearly €400,000 in damages from GlaxoSmithKline after a court agreed that her multiple sclerosis resulted from vaccination with GSK's Engerix B (hepatitis B vaccine). The newspaper Libération obtained a

  • GSK claims 'rapid progress' on swine flu vaccine

    Health Service Journal - 110 days 14 hours 24 minutes ago

    Drugs company GlaxoSmithKline says it is making rapid progress on its swine flu vaccine. Total doses ordered by governments worldwide so far total 291 million. The company aims to make the vaccine for the H1N1 swine flu virus available from September onwards with shipping expected in the second half of 2009 and early 2010. Although...

  • GSK to end corporate political contributions

    Medical Marketing and Media - 335 days 11 hours 54 minutes ago

    As part of its transparency push, GlaxoSmithKline is ending corporate political donations, though the company will continue to support a “voluntary and independent Political Action Committee” in the US.In a statement, GSK CEO Andrew Witty said: “We continue to believe that it is important for GSK to be engaged in policy debates and the...

  • GSK to appeal against French vaccines ruling

    Scrip News - 146 days 10 hours 39 minutes ago

    GlaxoSmithKline France says it will appeal against a civil tribunal's award of almost €400,000 in damages to a woman who claimed that vaccination with GSK's Engerix B (hepatitis B) in the 1990s caused her multiple sclerosis (scripnews.com, June

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement